PDF icon Download PDF
J Neurol Surg B Skull Base 2018; 79(01): 021-030
DOI: 10.1055/s-0037-1615810
Review Article
Georg Thieme Verlag KG Stuttgart · New York

Juvenile Angiofibroma: Current Management Strategies

Ahmad Safadi
1   Department of Otorhinolaryngology – Head and Neck Surgery and Maxillofacial Surgery, Tel Aviv Sourasky Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
,
Alberto Schreiber
2   Department of Otorhinolaryngology – Head and Neck Surgery, Spedali Civili of Brescia, University of Brescia, Brescia, Italy
,
Dan M. Fliss
1   Department of Otorhinolaryngology – Head and Neck Surgery and Maxillofacial Surgery, Tel Aviv Sourasky Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel
,
Piero Nicolai
2   Department of Otorhinolaryngology – Head and Neck Surgery, Spedali Civili of Brescia, University of Brescia, Brescia, Italy
› Author Affiliations
Further Information

Publication History

Publication Date:
18 January 2018 (online)

Also available atMedOne
   Permissions and Reprints
Preview

Abstract

Juvenile angiofibroma (JA) is a benign, highly vascular tumor which is diagnosed on the basis of clinical and imaging features. It has a characteristic pattern of spread commonly involving the pterygopalatine fossa and pterygoid base. The mainstay of treatment is surgery, while radiotherapy is rarely used for the treatment of recurrent lesion. Endoscopic endonasal surgery is currently the treatment of choice for small to intermediate size JAs, and is feasible even for advanced lesions; however, this should only be practiced in well-experienced centers.

Keywords

juvenile angiofibroma - endoscopic surgery - surgical treatment of juvenile angiofibroma